These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16005470)

  • 1. Mechanism of antithrombotic effect of heparin and antithrombin in balloon-injured arteries.
    Tomaru T; Kawano HA; Tsujiuchi Y; Suzuki J; Nakajima T; Uchida Y
    Life Sci; 2005 Oct; 77(21):2611-25. PubMed ID: 16005470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin and thrombolytic effects of a new antithrombin agent: angioscopic and angiographic comparison with heparin or batroxobin.
    Tomaru T; Nakamura F; Miwa AY; Fujimori Y; Omata M; Okada R; Uchida Y
    J Interv Cardiol; 1994 Oct; 7(5):409-19. PubMed ID: 10155190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of heparin inhibits neointimal hyperplasia in injured rabbit artery.
    Tomaru T; Yoshimura A; Inui K; Nakamura F; Omata M; Uchida Y
    Jpn Heart J; 1995 Sep; 36(5):657-68. PubMed ID: 8558770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local treatment with antithrombotic drugs can prevent thrombus formation: an angioscopic and angiographic study.
    Tomaru T; Nakamura F; Fujimori Y; Omata M; Kawai S; Okada R; Murata Y; Uchida Y
    J Am Coll Cardiol; 1995 Nov; 26(5):1325-32. PubMed ID: 7594050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries.
    Tomaru T; Nakamura F; Aoki N; Sakamoto Y; Omata M; Uchida Y
    Heart Vessels; 1996; 11(3):133-44. PubMed ID: 8897062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of thrombolysis and prevention of thrombus formation by local drug delivery with a double-occlusion balloon catheter.
    Tomaru T; Fujimori Y; Nakamura F; Aoki N; Sakamoto Y; Kawai K; Omata M; Uchida Y
    Heart Vessels; 1996; 11(3):123-32. PubMed ID: 8897061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.
    Duval N; Lunven C; O'Brien DP; Grosset A; O'Connor SE; Berry CN
    Br J Pharmacol; 1996 Jun; 118(3):727-33. PubMed ID: 8762100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local delivery of antithrombotic drug prevents restenosis after balloon angioplasty in atherosclerotic rabbit artery.
    Tomaru T; Fujimori Y; Morita T; Aoki N; Sakamoto Y; Nakamura F; Omata M; Uchida Y
    Jpn Circ J; 1996 Dec; 60(12):981-92. PubMed ID: 8996689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local antithrombotic therapy using a novel porous balloon catheter.
    Tomaru T; Kobayakawa N; Onitake A; Nakamura F; Morita T; Uchida Y
    Jpn Heart J; 2000 Jan; 41(1):87-95. PubMed ID: 10807533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
    Berry CN; Girard D; Lochot S; Lecoffre C
    Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
    Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
    Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
    Imura Y; Stassen JM; Vreys I; Lesaffre E; Gold HK; Collen D
    Thromb Haemost; 1992 Sep; 68(3):336-40. PubMed ID: 1440501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis.
    Berry CN; Visconte C; Lecoffre C; Lochot S; Girard D
    Thromb Haemost; 2000 Aug; 84(2):286-90. PubMed ID: 10959702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
    Imura Y; Stassen JM; Collen D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.
    Sato K; Kawasaki T; Hisamichi N; Taniuchi Y; Hirayama F; Koshio H; Matsumoto Y
    Br J Pharmacol; 1998 Jan; 123(1):92-6. PubMed ID: 9484858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of argatroban and heparin on thrombus formation and tissue plasminogen activator-induced thrombolysis in a microvascular thrombosis model.
    Yamada K; Tsuji H; Kimura S; Kato H; Yano S; Ukimura N; Yamada Y; Nakagawa K; Nakagawa M
    Thromb Res; 2003 Jan; 109(1):55-64. PubMed ID: 12679132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis.
    Heran C; Morgan S; Kasiewski C; Bostwick J; Bentley R; Klein S; Chu V; Brown K; Colussi D; Czekaj M; Perrone M; Leadley R
    Eur J Pharmacol; 2000 Feb; 389(2-3):201-7. PubMed ID: 10688985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin (fragmin) and thrombin active-site inhibitor (argatroban) compared in experimental arterial and venous thrombosis and bleeding time.
    Schumacher WA; Heran CL; Steinbacher TE
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):19-25. PubMed ID: 8797131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition.
    Zarge JI; Husak V; Huang P; Greisler HP
    Am J Surg; 1997 Aug; 174(2):188-92. PubMed ID: 9293842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.